Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Select Medical Holdings (SEM) Equity Income (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Equity Income for 9 consecutive years, with $12.0 million as the latest value for Q1 2026.

  • For Q1 2026, Equity Income fell 4.0% year-over-year to $12.0 million; the TTM value through Mar 2026 reached $54.0 million, down 13.32%, while the annual FY2025 figure was $54.5 million, 9.48% down from the prior year.
  • Equity Income hit $12.0 million in Q1 2026 for Select Medical Holdings, down from $15.4 million in the prior quarter.
  • Across five years, Equity Income topped out at $33.1 million in Q3 2024 and bottomed at $5.4 million in Q1 2022.
  • Average Equity Income over 5 years is $11.4 million, with a median of $10.4 million recorded in 2024.
  • Year-over-year, Equity Income surged 186.04% in 2024 and then crashed 60.71% in 2025.
  • Select Medical Holdings' Equity Income stood at $6.8 million in 2022, then surged by 50.84% to $10.2 million in 2023, then rose by 2.24% to $10.4 million in 2024, then surged by 47.74% to $15.4 million in 2025, then decreased by 22.0% to $12.0 million in 2026.
  • According to Business Quant data, Equity Income over the past three periods came in at $12.0 million, $15.4 million, and $13.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.